Position in BCRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,428,740
+$5,039,289 QoQ
Shares Held
1,642,874
+37.3% QoQ
Ownership
0.643%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#39
of 316 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $164,709,425 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
4,219,279 | $103,836,455 | |
| 2 | ZTS |
Zoetis Inc.
|
429,356 | $30,853,522 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
1,642,874 | $16,428,740 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
197,149 | $8,089,022 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
274,944 | $4,937,994 | |
| 6 | VTRS |
Viatris Inc
|
35,497 | $563,692 |
All Filings in BCRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,428,740 | 1,642,874 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $11,389,451 | 1,196,371 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $9,341,427 | 1,197,619 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $15,604,394 | 2,055,915 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $18,618,574 | 2,077,966 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $16,117,267 | 2,148,969 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $8,858,025 | 1,177,929 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $8,131,232 | 1,069,899 | Shares | Defined | 2024-11-12 | |
| 2021-12-31 | $868,450 | 62,704 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||